- APRE Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Aprea Therapeutics (APRE) 8-K23 Oct 24Preliminary results to date demonstrate APR-1051 is safe and well-tolerated with no hematologic toxicityFinancial data
Company Profile